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Abstract 
Objectives: Thrombolysis for acute ischaemic 
stroke was introduced locally in October 2010. In 2012, 
the practice was audited to analyse the prevalence of 
inclusion and exclusion criteria for thrombolysis. Data 
about the local incidence of stroke, demographics and 
outcome was also obtained. 
Methods: All patients admitted to Mater Dei 
Hospital with a diagnosis of stroke over an 8 month 
period were recruited.  Standard data collection sheets 
were used to obtain data. 
Results: 251 patients were admitted with a 
confirmed stroke over the 8-month period. The time of 
onset was recorded in only 37.4% of cases. All patients 
had CT scanning of the brain within 24 hours of 
presentation, of which 70% were performed within 3 
hours. The commonest 5 reasons for which thrombolysis 
was withheld were: presentation beyond 3 hours of 
symptom onset (73.7%), age over 80 years (29.9%), 
hypertension (13.9%), haemorrhagic stroke (13.1%) and 
minor deficit or rapid improvement (8.4%). Overall, 
only 4 patients (1.59%) were eligible for thrombolysis in 
our cohort, all of whom received the treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion: The study identified late 
presentation to A&E as the commonest exclusion 
criterion for thrombolysis. This prompted the launch of a 
stroke awareness ‘Act FAST’ campaign and increasing 
efforts to educate general practitioners to refer patients 
with acute stroke immediately. In addition, stroke 
pathway booklets were reviewed and simplified to 
increase their use. Since July 2013, the time window has 
been widened to 4.5 hours in accordance with 
international guidelines. Ongoing audit of thrombolysis 
is being carried out. 
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Introduction 
Background 
Most strokes occur secondary to arterial occlusion 
in the circulation to the brain. Thrombolysis in such 
circumstances was first studied in the late 1960s and the 
1970s but these studies had to be abandoned in view of a 
high risk of intracranial haemorrhage. Since then, new 
thrombolytic agents such as recombinant tissue 
plasminogen activator (rtPA) have been developed. 
Studies carried out in late 1980s and early 1990s 
reported positive outcomes with respect to recanalisation 
and safety of the new drugs.1 The positive results 
prompted further studies, including a larger randomised, 
placebo-controlled trial by the National Institute of 
Neurological Diseases and Stroke, the results of which 
were published in 1995. This study ensured that patients 
were treated within 3 hours of symptom onset and found 
that there was significant benefit in patients who 
received thrombolysis, compared to those treated with 
placebo. This benefit was evident at three months from 
stroke onset, with no increase in mortality.2 The first 
National Clinical Guidelines for Stroke were published 
by the Royal College of Physicians (RCP) in the year 
2000. At the time, the use of rtPA was limited to 
specialist centres under strict criteria. The drug was not 
yet licensed in the UK.3 In contrast, latest RCP 
guidelines published in 2012 recommend that 
thrombolysis is considered within 3 hours of symptom 
onset “regardless of age or stroke severity” provided 
there are no contraindications. Patients under the age of 
80 should be considered for treatment between 3 and 4.5 
hours of symptom onset.4 
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Aims of the audit 
In 2008, after the publication of the third edition of 
the National Clinical Guidelines for Stroke by the Royal 
College of Physicians of London, a local audit was 
carried out to compare the practice with the standards set 
by the guideline.5 
Based on the results of the audit, stroke guidelines 
were formulated at Mater Dei Hospital. These have been 
readily available as booklets at the Accident and 
Emergency department. The pathways were introduced 
in October 2010 together with a thrombolysis service, 
aiming to ensure that patients eligible for thrombolysis 
are identified at triage and are fast-tracked through the 
necessary investigations. The documents also cover the 
management of patients who do not receive 
thrombolysis based on international recommendations. 
In 2012 a second study was carried out. The main 
aim was to audit the practice of thrombolysis in acute 
ischaemic stroke with an analysis of the prevalence of 
the inclusion and exclusion criteria. Secondary aims 
included obtaining data about the incidence of stroke, 
demographics and outcome. 
The results were then analysed to identify any 
outstanding inclusion or exclusion criteria that could be 
addressed in order to increase the number of patients 
who could benefit from this treatment. 
 
Methodology 
Patient Population  
 The audit covered the 8-month period between the 
1st March and the 31st October 2012. Patients who were 
discharged with an alternative diagnosis including that 
of a transient ischaemic attack, were excluded. In-patient 
strokes were not included due to the absence of an 
effective mechanism to identify these patients. 
 
Data collection Sheet Design 
Standard data collection sheets were designed. Data 
collected in the audit was based on the content of local 
stroke guideline booklets. The audit focused on the 
inclusion/exclusion criteria for thrombolysis.  
 
Data Collection 
Ethical approval was obtained from the University 
of Malta Research Ethics Committee. Data was collected 
prospectively, recording documentation of assessment, 
results and management.  Sources of data collection 
included access to patient files, nursing notes, PACS 
(Picture Archiving and Communications System), 
iSOFT (Healthcare Software) and ECS (Electronic Case 
Summary).  
 
Results 
Recruitment 
Over the 8-month period of the audit, a total of 321 
patients were admitted to hospital with a clinical 
diagnosis of stroke, of which 70 were excluded due to a 
different discharge diagnosis.  
 
Demographics 
The total number of patients included was 251; of 
whom 137 were male and 114 female. The mean age 
was 73 years (range 21 – 95), with a median age of 75 
years.  
 
Time of onset, presentation and discharge outcome 
The time of onset of symptoms was known in 
37.4% of patients (n=94). Of those with unknown onset, 
7.9% (n=20) were wake up strokes. 72.6% (n=182) 
presented to the emergency department between 8.00 
a.m. and 8.00 p.m (Figure 1). Figure 2 displays the type 
of stroke classified by the arterial territory involved, if it 
was possible to determine it clinically or by imaging. 
26.2% (n=66) presented within 3 hours of initial 
symptoms (Figure 3).  
 
Figure 1: Percentage of strokes classified by time of 
symptom onset 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Type of stroke as determined by 
symptomatology and/or imaging 
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Figure 3: Time frame between symptom onset and 
presentation to the Accident and Emergency Department 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Brain imaging 
All patients presenting with a presumed stroke 
underwent CT scanning of the brain within 24 hours of 
presentation. 70% of scans were performed within 3 
hours of presentation. Data regarding the timeframe 
between symptom onset and CT scanning is limited 
because the time of onset was only documented in a 
minority of cases. The time delay from symptom onset 
and from presentation to CT imaging is illustrated in 
figure 5. 
 
 
Figure 4: Pie chart showing the discharge 
destination of patients admitted with stroke 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Pie charts showing the time frame between (a) 
symptom onset and (b) time of presentation to cross-
sectional brain imaging 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The scans showed features of early ischaemic 
change in 51 patients (20.3%), extensive ischaemic 
change (more than a third of MCA territory) in 10 
patients (4.0%), and haemorrhage in 33 patients 
(13.1%). No significant abnormality was reported in the 
remaining cases. Results of CT scans are presented in 
figure 6. 
 
Figure 6: Findings on cross-sectional brain 
imaging of patients admitted with a diagnosis of stroke 
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Figure 7: Reasons why thrombolysis could not be offered 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thrombolysis 
4 patients (1.59%) were eligible for thrombolysis 
after evaluation of all the inclusion and exclusion 
criteria, all of whom accepted to receive this treatment 
modality. The commonest ten reasons why thrombolysis 
could not be offered to the patients are listed below and 
shown in figure 7:  
 
1. presentation after 3 hours of onset of symptoms: 
185 patients (73.7%)  
2. age >80 years: 75 patients (29.9%)  
3. blood pressure above 185/110 mmHg: 35 patients 
(13.9 %)  
4. haemorrhagic stroke: 33 patients (13.1%)  
5. minor deficit or improving symptoms: 21 patients 
(8.4%)  
6. signs and symptoms not diagnostic of stroke: 19 
patients (7.6%) 
7. prior anticoagulation: 19 patients (7.6%)  
8. diabetes with previous stroke: 19 patients (7.6%)  
9. symptoms lasting less than 30 minutes: 14 patients 
(5.6%) 
10. seizures: 11 patients (4.4%)  
 
The characteristics of the thrombolysed patients are 
presented in the table below: 
 
 
 
 
Table 1: Characteristics of the thrombolysed patients 
 
P
at
ie
n
t 
A
g
e 
S
ex
 
N
IH
S
S
 
C
T
 m
in
 
C
o
m
p
li
ca
ti
o
n
s 
o
f 
rT
P
A
 
2
4
h
 
N
IH
S
S
 
O
u
tc
o
m
e 
1 57 M 9 11 No 4 Rehabilitation 
2 57 F 11 9 No 13 Rehabilitation 
3 59 M 14 28 No 15 
Died after 4 
days 
4 65 M 11 41 No 15 Home 
 
Documentation  
Documentation was found to be poor in the audit, 
even after introduction of the stroke pathway booklets. 
The ROSIER scale used at triage of patients at the 
Accident and Emergency Department was completely 
and appropriately filled in most cases. However the 
stroke booklet was filled only in a minority of cases, and 
the data was scattered. National Institute of Health 
Stroke Scale (NIHSS) was documented for only 55 
patients (22%). Documentation of the presence of 
inclusion or exclusion criteria was often absent or 
unclear. For example, for 9 patients for whom 
thrombolysis was withheld, the reason was only evident 
after going through the patients’ case notes thoroughly. 
 
Discussion 
Thrombolytic therapy is of proven and substantial 
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benefit for select patients with acute cerebral ischaemia. 
The evidence for thrombolysis in stroke to date includes 
21 completed randomized controlled clinical trials 
enrolling 7152 patients, using various agents, doses, 
time windows, and intravenous or intra-arterial modes of 
administration.6 
Despite being the most effective therapy if 
instituted within the first 4.5 hours, thrombolysis is still 
underused worldwide.7 A study published from the 
Intercollegiate Working Party for Stroke showed that 
thrombolysis rates are currently low in the UK. 28% of 
patients presented within 3 hours of admission. Of these 
only 14% met all four National Institute of Neurological 
Disorders and Stroke study inclusion criteria. By 
increasing the time window to 4.5 hours only another 
2% became eligible. Overall only 1.4% of patients were 
thrombolysed8, which is in fact comparable to our 
1.59%. Locally, the time window has been widened 
from 3 to 4.5 hours of symptom onset since July 2013, in 
accordance with international guidelines based on 
ECASS-3 trial results.9 
The local guidelines introduced in October 2010 
were geared at recognising patients who will be eligible 
for thrombolysis from triage. Despite short distances and 
relatively easy access to medical services in Malta, we 
note that delayed presentation to A&E was the 
commonest reason for non-suitability for thrombolysis. 
Prompt presentation relies on the patients' or witnesses’ 
ability to identify physical changes and recognize the 
need for urgent medical assistance.  Hence the call for 
nationwide promotion of stroke awareness, by simple 
achievable means, such as advertising on public media 
the ‘Act FAST’ campaign – i.e. “Facial weakness, Arm 
weakness or Speech problems? Time to call emergency 
services”. Stroke awareness leaflets have been 
developed in collaboration with the Health Promotion 
Department and launched in October 2013. Likewise, 
since 2008, there have been efforts to educate general 
practitioners to refer immediately and appropriately for 
medical treatment. The results of a public education 
campaign will probably take time to become evident but 
efforts at continuing to raise the awareness should 
intensify.  
Poor compliance with the use of local guideline 
booklets raised the necessity to review the stroke 
pathway booklets and simplify them to make them more 
user-friendly. Review of these booklets was 
accompanied by refresher courses for the medical 
doctors in the department of A&E and department of 
Medicine. The local guidelines are continuously being 
updated, based on the recent changes in international 
guidelines4. 
These efforts seek to increase the number of 
patients who benefit from thormbolysis. To date, 37 
patients have received this treatment for ischaemic 
stroke. Ongoing audit of thrombolysis is being carried 
out. We hope to publish results after five years of 
service. 
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